Business
Isodiol International Inc. Launches ISOCare, an Innovative Platform for the Cannabis Treatment Industry
Isodiol International Inc. Launches ISOCare, an Innovative Platform for the Cannabis Treatment Industry.
About this update from Isodiol International Inc
[{"type":"text","content":"\nVANCOUVER, B.C., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLD) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator and market leader, in conjunction with Livecare is proud to announce the launch of ISOCare in North American and Latin American markets. ISOCare is an innovative secure platform for the cannabis treatment industry that enables and supports physicians in the longitudinal care of their patients' health. The Company had previously announced its licensing agreement with Livecare on January 26, 2018.\n ISOCare will allow collaborative care with doctors and mentor certified cannabis practitioners to achieve health outcomes including medicinal cannabis therapies. The ISOCare platform connects patients with providers for a medical visit, through a mobile or PC device, eliminating many of the inconveniences faced today in the physician and patient relationship. To access the ISOCare platform, patients must simply complete their initiation form, which doctors then review before connecting with patients via video conference.  From there, physicians may prescribe medications, or discuss any other concerns. Additionally, the Company believes ISOCare will permit higher patient retention in clinical studies because it will make it easier for enrollees and clinical studies to report back to sponsors. “We believe ISOCare to be an innovative platform that allows patients’ family doctors to involve a certified cannabis physician in continuing longitudinal care while enjoying the benefits of health and wellness products,” said CEO of Isodiol, Marcos Agramont. “The Company believes ISOCare will also permit higher patient retention in clinical studies, as the process for the patients and clinical studies to report back to sponsors will become much easier. Additionally, this platform allows consumers, particularly in rural areas, to conveniently seek access to our products at their convenience.” Added CEO of Livecare, Dr. Mark Godley, “Livecare is excited to empower ISOCare’s platform in its efforts to expand access to physicians with the primary goal of improved longitudinal care.” The Company is continuously collaborating with government officials to ensure full compliance with ISOCare and as legis...